Q Key Stats
|Revenue (Quarterly YoY Growth)||-0.31%|
|EPS Diluted (TTM)||1.506|
|EPS Diluted (Quarterly YoY Growth)||13.64%|
|Net Income (TTM)||188.57M|
|Gross Profit Margin (Quarterly)||27.77%|
|Profit Margin (Quarterly)||5.58%|
|Dividend Yield (TTM)||4.75%|
|Payout Ratio (TTM) Pro||Go Pro|
- Deutsche Bank Assumes Quintiles (Q) at Hold Street Insider Nov 21
- Analysts' Actions: AAP FB LNKD PXD Q Nov 21
- [video] Cramer's Six in 60: Careful of biotech stocks CNBC Nov 1
- Baird Upgrades Quintiles (Q) to Outperform Street Insider Nov 1
- Quintiles upgraded to Outperform from Neutral at RW Baird Nov 1
- Jim Cramer's 6 Stocks in 60 Seconds: VRTX GTLS YELP AVD Q GRPN Nov 1
- Quintiles Transnational Holdings Management Discusses Q3 2013 Results - Earnings Call Transcript Seeking Alpha Oct 31
- Q3 2013 Quintiles Transnational Holdings Inc Earnings Release - Before Market Open Oct 31
- Quintiles raises forecast as new business jumps 29 pct Oct 31
- Quintiles President & COO John Ratliff to Leave Company at End of 2013 noodls Oct 31
Q Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Quintiles Transnational is up N/A over the last year vs S&P 500 Total Return up 30.02%, Covance up 45.51%, and Parexel International up 21.50%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for Q
Pro Report PDF for Q
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download Q Pro Report PDF
Pro Strategies Featuring Q
Did Quintiles Transnational make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Quintiles Transnational Holdings Inc provides biopharmaceutical development services and commercial outsourcing services. It operates in two segment namely Product Development segment and Integrated Healthcare Services segment.